# EDGAR Filing Document

**Accession Number:** 0002079720
**File Stem:** 0000000000-25-011397
**Filing Date:** 2025-12
**Character Count:** 11166
**Document Hash:** 0ecf7d8bc30d367d77eeabb5fa5f97c5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-011397.hdr.sgml**: 20260416

**ACCESSION NUMBER**: 0000000000-25-011397

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20251209

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BUDA JUICE, INC.
- **CENTRAL INDEX KEY:** 0002079720
- **STANDARD INDUSTRIAL CLASSIFICATION:** BEVERAGES [2080]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 464069365
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-289874

**BUSINESS ADDRESS:**
- **STREET 1:** 4030 BLACK GOLD DRIVE
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75247
- **BUSINESS PHONE:** 214-742-9999

**MAIL ADDRESS:**
- **STREET 1:** 4030 BLACK GOLD DRIVE
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75247

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Buda Juice LLC
- **DATE OF NAME CHANGE:** 20250801
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001493152-25-012359

## Text-Extract

```

                                                            December 9, 2025

Horatio Lonsdale-Hands
Chief Executive Officer
Buda Juice, LLC
4030 Black Gold Drive,
Dallas, Texas 75247

       Re: Buda Juice, LLC
           Amendment No. 4 to Registration Statement on Form S-1
           Filed December 1, 2025
           File No. 333-289874
Dear Horatio Lonsdale-Hands:

     We have reviewed your amended registration statement and have the
following
comments.

        Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe a comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

        After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments. Unless
we note
otherwise, any references to prior comments are to comments in our September
23, 2025
letter.

Amendment No. 4 to Registration Statement on Form S-1
Risk Factors
Risks Relating to This Offering, page 28

1.     We note that your forum selection provision identifies a state court
located within the
       State of Delaware (or, if no state court located within the State of
Delaware has
       jurisdiction, the federal district court for the District of Delaware)
as the exclusive
       forum for certain litigation, including any    derivative action.
Please disclose whether
       this provision applies to actions arising under the Securities Act or
Exchange Act. If
       so, please also state that there is uncertainty as to whether a court
would enforce such
       provision. Revise to discuss the risks related to increased costs to
bring a claim and
       that these provisions can discourage claims or limit investors
ability to bring a claim
 December 9, 2025
Page 2

       in a judicial forum that they find favorable. If the provision applies
to Securities Act
       claims, please also state that investors cannot waive compliance with
the federal
       securities laws and the rules and regulations thereunder. In that
regard, we note that
       Section 22 of the Securities Act creates concurrent jurisdiction for
federal and state
       courts over all suits brought to enforce any duty or liability created
by the Securities
       Act or the rules and regulations thereunder. If this provision does not
apply to actions
       arising under the Securities Act or Exchange Act, please also ensure
that the exclusive
       forum provision in the governing documents states this clearly, or tell
us how you will
       inform investors in future filings that the provision does not apply to
any actions
       arising under the Securities Act or Exchange Act. Finally, discuss this
forum selection
       provision in the Description of Capital Stock section.
Business
Intellectual Property, page 52

2.     We note your revisions in response to prior comment 8 and reissue in
part. Please
       disclose the duration of your trademarks.
Management, page 55

3.     We note disclosure in the table on page 55 that Mo Hayat is a director
nominee and
       that your board is expected to be comprised of seven directors. This
appears
       inconsistent with disclosure on page 58 that your board is expected to
be comprised of
       six directors. Please advise or revise. Further, please update your
beneficial ownership
       table on page 64 to provide information for Mo Hayat. Finally, please
revise to update
       the bracketed information on pages 58 to 60 related to your director
independence and
       committee memberships.
Executive and Director Compensation
Director Compensation, page 62

4.     We note your revisions in response to prior comment 11 and reissue in
part. Please
       provide compensation information for the last completed fiscal year for
Bryan Herr,
       Bernard Lucien Nussbaumer and Horatio Lonsdale-Hands. Refer to Item
402(r) of
       Regulation S-K.
Principal Stockholders, page 64

5.     Please tell us how you calculated the totals in the    All directors and
executive officers
       as a group    row. In this regard, it appears that the share ownership
for each beneficial
       owner is identical in the    Beneficial Ownership Before the Offering
Common Stock
       and    Beneficial Ownership After the Offering Common Stock    columns
except for
       that of Horatio Lonsdale-Hands   s beneficial ownership, which reflects
the Stock
       Redemption of 500,000 shares per footnote (4). However, the difference
in the    All
       directors and executive officers as a group    totals for the two
columns is 500,360
       shares instead of 500,000 shares. Further, we note that the    All
directors and
       executive officers as a group    row includes the shares beneficially
owned by 2469447
       Ontario Ltd., your 5% stockholder. However, we note that there is no
indication that
       this stockholder is related to your directors and executive officers.
Please advise or
       revise.
 December 9, 2025
Page 3

Exhibit 10.1 Stock Incentive Plan, page II-2

6.     We note your response to prior comment 17 and reissue in part. Please
file your
       indemnification agreements with each of your directors and executive
officers.
       Further, please reconcile the description of Exhibit 10.1 in the exhibit
index, which
       appears inconsistent with the exhibit title of 2025 Equity Incentive
Plan. Additionally,
       please advise if Exhibit 10.1 is the same as the    2025 Incentive Award
Plan
       referenced on page 62 and revise to clarify. Finally, please revise the
Executive and
       Director Compensation section to disclose the material terms of Exhibit
10.1 and the
       2025 Incentive Award Plan.
Exhibit 107 Filing Fee Table, page II-2

7.     We note that you are relying on Rules 457(o) and 457(g). Please revise
the
          Maximum Aggregate Offering Price    column of your fee table to
reflect the
       maximum offering price that you disclose in your prospectus for all
offered securities,
       including the over-allotment shares to be offered to the public and
underwriter
       warrants or advise. In this regard, it appears that you used the low end
of your price
       range of $7.50 instead of the high end range of $9.
Exhibit 5.1 Opinion of Lucosky Brookman LLP, page II-2

8.     It appears that the underwriter   s warrants will be governed by New
York law. Refer to
       Sections 6(e) of the Form of Underwriter   s Warrants and 8.6 of the
Initial Form of
       Underwriting Agreement, filed as Exhibits 4.2 and 1.1, respectively. If
true, please
       have New York counsel opine that the warrants are a binding obligation
of the
       registrant under the law of the jurisdiction governing the warrant
agreement, and
       update the Experts section as appropriate. Refer to Sections II.B.1.f
and II.B.3.b of
       Staff Legal Bulletin No. 19.
Part II Information Not Required in Prospectus
Item 16. Exhibits and Financial Statement Schedules, page II-2

9.     Please revise to update your exhibit index as follows:
           Please file your articles of incorporation and bylaws or instruments
corresponding
           thereto as currently in effect. Refer to Items 601(b)(3)(i) and
601(b)(3)(ii) of
           Regulation S-K.
           We note that you deleted Exhibit 4.1 Form of Registrant   s Common
Stock Share
           Certificate. Please revise to file this exhibit.
           Please refile Exhibits 10.3 and 10.4 in the proper text-searchable
format. Refer to
           Section 5.2.3.6 of the EDGAR Filer Manual (Volume II) EDGAR Filing
(Version
           75, June 2025) and Item 301 of Regulation S-T.
General

10.    Please revise disclosures throughout the filing to update and/or
reconcile apparent
       inconsistencies, including the following:
           We note your response to prior comment 19 and reissue in part. We
note
           disclosure on page 59 still provides that Barrett Evans is expected
to serve on
 December 9, 2025
Page 4

           your audit committee. However, this individual is not disclosed on
page 55.
           Please revise to clarify.
             Reconcile disclosure on the cover page that you are registering
266,666 shares of
           Common Stock underlying warrants with disclosure elsewhere that this
number is
           266,667.
             Reconcile disclosure on page 8 that you intend to apply to have
your Common
           Stock listed on NYSE with disclosure on page 74 that your Common
Stock is
           listed on NYSE.
             We note disclosure on page 40 regarding lease obligations of (i)
$188 due within
           the next 12 months; (ii) $683 due beyond 12 months; (iii) $793 due
through 2030;
           and (iv) future minimum lease payments of approximately $981. It
appears that
           these numbers should be in thousands. In this regard, refer to the
disclosure on
           page F-10 of future lease obligations stated in thousands. Please
advise or revise.
             Reconcile references to    articles of incorporation and bylaws,
    amended and
           restated certificate of incorporation and amended and restated
bylaws,    and
              certificate of incorporation and bylaws    to clarify if these
titles refer to the same
           documents. Refer to pages 31, 65 and II-2.

       Please contact Jeff Gordon at 202-551-3866 or Kevin Woody at
202-551-3629 if you
have questions regarding comments on the financial statements and related
matters. Please
contact Jenny O'Shanick at 202-551-8005 or Anne Parker at 202-551-3611 with any
other
questions.

                                                              Sincerely,

                                                              Division of
Corporation Finance
                                                              Office of
Manufacturing
cc:   Soyoung Lee

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._